Structure and function of nicotinic acetylcholine receptor (nAChR) - Subtypes expressed in the mesostriatal dopamine (DA) pathways in normal and pathological conditions

被引:0
|
作者
Gotti, C
Zoli, M
机构
[1] Univ Milan, Dept Med Pharmacol, Cellular & Mol Pharmacol Sect, CNR,Inst Neurosci, Milan, Italy
[2] Univ Modena & Reggio Emilia, Physiol Sect, Dept Biomed Sci, Modena, Italy
关键词
D O I
暂无
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
引用
收藏
页码:657 / 657
页数:1
相关论文
共 6 条
  • [1] Structure Function Studies at Two Different Nicotinic Acetylcholine Receptor Subtypes
    Post, Michael R.
    Lester, Henry A.
    Dougherty, Dennis A.
    BIOPHYSICAL JOURNAL, 2014, 106 (02) : 341A - 341A
  • [2] α-Conotoxins as tools for the elucidation of structure and function of neuronal nicotinic acetylcholine receptor subtypes
    Nicke, A
    Wonnacott, S
    Lewis, RJ
    EUROPEAN JOURNAL OF BIOCHEMISTRY, 2004, 271 (12): : 2305 - 2319
  • [3] INSULIN-RECEPTOR STRUCTURE AND FUNCTION IN NORMAL AND PATHOLOGICAL CONDITIONS
    BECKER, AB
    ROTH, RA
    ANNUAL REVIEW OF MEDICINE, 1990, 41 : 99 - 115
  • [4] The α7 nicotinic acetylcholine receptor (nAChR) allosteric modulator UCI-40083 differentially increases dopamine (DA) and norepinephrine (NE) release in adolescent rat brain
    Carboni, E.
    Ibba, M.
    Cadeddu, R.
    Hogenkamp, D.
    Johnstone, T.
    Gee, K. W.
    BIOCHEMICAL PHARMACOLOGY, 2011, 82 (08) : 1042 - 1043
  • [5] Structure-Activity Considerations for Heteroaromatic nortropeines and N-methyltropeines with Nicotinic Acetylcholine Receptor (nAChR) Subtypes and a Serotonin Receptor (5HT3A)
    Serrano, Aracely
    Nemecz, Akos
    Gomez, Kimberly
    Gabor Maksay
    Yamahuchi, John George
    Taylor, Palmer
    FASEB JOURNAL, 2013, 27
  • [6] Heterogeneity and selective targeting of neuronal nicotinic acetylcholine receptor (nAChR) subtypes expressed on retinal afferents of the superior colliculus and lateral geniculate nucleus:: Identification of a new native nAChR subtype α3β2(α5 or β3) enriched in retinocollicular afferents
    Gotti, C
    Moretti, M
    Zanardi, A
    Gaimarri, A
    Champtiaux, N
    Changeux, JP
    Whiteaker, P
    Marks, MJ
    Clementi, F
    Zoli, M
    MOLECULAR PHARMACOLOGY, 2005, 68 (04) : 1162 - 1171